NEW YORK, April 7, 2017 /PRNewswire/ --
On Thursday, the NASDAQ Composite ended the day at 5,878.95, up 0.25%; theDow Jones Industrial Average edged 0.07% higher, to finish at 20,662.95; and the S&P 500 closed at 2,357.49, marginally gaining 0.19%. Gains were broad based as six out of nine sectors finished the trading session in green. Stock-Callers.com has
On Thursday, shares in Arlington, Virginia headquartered Evolent Health Inc. ended the session 1.12% lower at $22.15 with a total volume of 812,505 shares traded. Evolent Health's shares have surged 12.72% in the last one month and 46.69% in the previous three months. Furthermore, the Company's stock has rallied 104.71% in the past one year. The stock is trading 10.86% above its 50-day moving average and 6.99% above its 200-day moving average. Moreover, shares of the Company, which through its subsidiary, Evolent Health LLC, provides healthcare delivery and payment solutions in the US, have a Relative Strength Index (RSI) of 58.36.
On March 14th, 2017, research firm Oppenheimer initiated an 'Outperform' rating on the Company's stock. EVH complete research report is just a click away and free at:
On Thursday, shares in Draper, Utah headquartered HealthEquity Inc. recorded a trading volume of 366,979 shares. The stock ended the day 0.42% higher at $42.67. Shares of the Company, which provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the US, are trading at a PE ratio of 96.76. HealthEquity's stock has advanced 1.76% in the last one month and 4.63% in the previous three months. Furthermore, the stock has surged 66.68% in the past one year. The Company's shares are trading above its 200-day moving average by 12.80%. Furthermore, HealthEquity's shares have an RSI of 50.06.
On March 31st, 2017, research firm Cantor Fitzgerald initiated an 'Overweight' rating on the Company's stock. The complimentary report on HQY can be downloaded at:
Charlotte, North Carolina headquartered Premier Inc.'s stock finished Thursday's session 1.86% higher at $32.26 with a total volume of 475,219 shares traded. Over the last one month and the previous three months, Premier's shares have advanced 4.74% and 3.66%, respectively. The Company's shares are trading above its 50-day and 200-day moving averages by 3.13% and 2.18%, respectively. Shares of Premier, which together with its subsidiaries, operates as a healthcare improvement company in the US, are trading at a PE ratio of 5.74. The stock has an RSI of 63.20.
On March 28th, 2017, research firm Bank of America/ Merrill upgraded the Company's stock rating from 'Underperform' to 'Buy'. Sign up for your complimentary research report on PINC at:
New York headquartered Medidata Solutions Inc.'s stock advanced 2.93%, to close the day at $59.80. The stock recorded a trading volume of 488,120 shares, which was above its three months average volume of 439,740 shares. Medidata Solutions' shares have gained 5.60% in the last one month, 15.35% in the previous three months, and 51.43% in the past one year. The Company's shares are trading 8.68% and 13.39% above its 50-day and 200-day moving averages, respectively. Shares of the Company, which provides cloud-based solutions for life sciences worldwide, are trading at a PE ratio of 117.72. Additionally, the stock has an RSI of 71.14. Get free access to your research report on MDSO at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: email@example.com Phone number: +44-330-808-3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA
Subscribe to our Free Newsletters!
Steroids are miracle drugs but have to be used with caution. Some steroids are illegal to use, ...
Abruptio placenta is a serious but rare complication of pregnancy where a separation of placenta ...
Cyanosis is the bluish or purplish discoloration of the skin and mucus membranes due to lack of ...View All